Latest news
Cytosorbents Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CTSO) 2026-08-09 - Seeking AlphaSeeking Alpha · Sun, 09 Aug 2026 23:07:07 GMTUS$2.88: That's What Analysts Think Cytosorbents Corporation (NASDAQ:CTSO) Is Worth After Its Latest Results - simplywall.stsimplywall.st · Sun, 09 Aug 2026 13:08:03 GMTCytosorbents Corp (CTSO) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 21:51:31 GMTCytoSorbents posts $9.6M Q2 revenue, narrows cash burn and advances DrugSorb-ATR regulatory path - TradingViewTradingView · Fri, 07 Aug 2026 20:13:12 GMTCytoSorbents (NASDAQ: CTSO) posts Q2 2026 revenue of $9.6M and narrows loss - Stock TitanStock Titan · Fri, 07 Aug 2026 20:07:30 GMTCytosorbents Corp. R (HQE1.DU) Q1 FY2026 earnings call transcript - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:02:45 GMTCytoSorbents Corp (CTSO) (Q2 2026) Earnings Call Highlights: Nea - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:16:55 GMTCytoSorbents Q2 2026: Flat Revenue, Improved Cash Burn Ahead of DrugSorb-ATR FDA Decision - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMT